钠氢交换体激活与抑制:连接糖尿病与心力衰竭病理生理及治疗的机制
2型糖尿病与心力衰竭的进展相互交织,钠氢交换体(NHE1/NHE3)激活可能是共同机制。心衰时神经激素系统激活可损害胰岛素敏感性,而糖尿病相关异常也是心衰特征。抑制NHE可能同时改善两种疾病,共存时NHE抑制剂疗效可能增强,联合NHE抑制作用的药物可能减弱疗效。
要点
- NHE1(心脏/血管)和NHE3(肾脏)激活是糖尿病与心衰的共同通路
- 心衰神经激素激活损害胰岛素敏感性,糖尿病异常促进心衰进展
- NHE抑制剂在合并心衰与糖耐量异常时心血管获益可能增强
核心结论
- 钠氢交换体(NHE1和NHE3)激活可能是连接糖尿病与心衰病理生理及临床进展的核心机制。
- NHE抑制剂的心血管事件获益在心力衰竭与糖耐量异常共存时可能增强,而联用具有NHE抑制作用的药物时可能减弱。
研究设计与样本
- 本文为综述,未报告系统检索策略、样本量或研究设计细节。
主要发现
- 胰岛素不敏感和脂肪因子异常是2型糖尿病标志,也是心衰特征;心衰中激活的去甲肾上腺素、血管紧张素II、醛固酮和脑啡肽酶可损害胰岛素敏感性并促进糖尿病微血管病变。
- 上述神经激素紊乱可能通过增加NHE1和NHE3活性发挥作用,降糖药和心衰治疗药物可能通过抑制NHE产生相互有益影响。
临床怎么用
- 临床关注糖尿病与心衰共存患者,NHE抑制剂在此类患者中可能获益更明显。
- 注意联用具有NHE抑制作用的药物可能减弱NHE抑制剂的心血管获益。
局限性
- 本文为综述,未提供原始研究数据、样本量、效应值或统计显著性,结论基于机制推理和已有试验的间接证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The mechanisms underlying the progression of diabetes mellitus and heart failure are closely intertwined, such that worsening of one condition is frequently accompanied by worsening of the other; the degree of clinical acceleration is marked when the 2 coexist. Activation of the sodium-hydrogen exchanger in the heart and vasculature (NHE1 isoform) and the kidneys (NHE3 isoform) may serve as a common mechanism that links both disorders and may underlie their interplay. Insulin insensitivity and adipokine abnormalities (the hallmarks of type 2 diabetes mellitus) are characteristic features of heart failure; conversely, neurohormonal systems activated in heart failure (norepinephrine, angiotensin II, aldosterone, and neprilysin) impair insulin sensitivity and contribute to microvascular disease in diabetes mellitus. Each of these neurohormonal derangements may act through increased activity of both NHE1 and NHE3. Drugs used to treat diabetes mellitus may favorably affect the pathophysiological mechanisms of heart failure by inhibiting either or both NHE isoforms, and drugs used to treat heart failure may have beneficial effects on glucose tolerance and the complications of diabetes mellitus by interfering with the actions of NHE1 and NHE3. The efficacy of NHE inhibitors on the risk of cardiovascular events may be enhanced when heart failure and glucose intolerance coexist and may be attenuated when drugs with NHE inhibitory actions are given concomitantly. Therefore, the sodium-hydrogen exchanger may play a central role in the interplay of diabetes mellitus and heart failure, contribute to the physiological and clinical progression of both diseases, and explain certain drug-drug and drug-disease interactions that have been reported in large-scale randomized clinical trials.
引用
- Packer M. Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure. Circulation. 2017. PMID: 29038209. doi:10.1161/CIRCULATIONAHA.117.030418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。